Synergistic role of activated CD4+ memory T cells and CXCL13 in augmenting cancer immunotherapy efficacy

The development of immune checkpoint inhibitors (ICIs) has significantly advanced cancer treatment. However, their efficacy is not consistent across all patients, underscoring the need for personalized approaches. In this study, we examined the relationship between activated CD4+ memory T cell expre...

Full description

Bibliographic Details
Main Authors: Wenhao Ouyang, Qing Peng, Zijia Lai, Hong Huang, Zhenjun Huang, Xinxin Xie, Ruichong Lin, Zehua Wang, Herui Yao, Yunfang Yu
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024031827
_version_ 1797259807859671040
author Wenhao Ouyang
Qing Peng
Zijia Lai
Hong Huang
Zhenjun Huang
Xinxin Xie
Ruichong Lin
Zehua Wang
Herui Yao
Yunfang Yu
author_facet Wenhao Ouyang
Qing Peng
Zijia Lai
Hong Huang
Zhenjun Huang
Xinxin Xie
Ruichong Lin
Zehua Wang
Herui Yao
Yunfang Yu
author_sort Wenhao Ouyang
collection DOAJ
description The development of immune checkpoint inhibitors (ICIs) has significantly advanced cancer treatment. However, their efficacy is not consistent across all patients, underscoring the need for personalized approaches. In this study, we examined the relationship between activated CD4+ memory T cell expression and ICI responsiveness. A notable correlation was observed between increased activated CD4+ memory T cell expression and better patient survival in various cohorts. Additionally, the chemokine CXCL13 was identified as a potential prognostic biomarker, with higher expression levels associated with improved outcomes. Further analysis highlighted CXCL13's role in influencing the Tumor Microenvironment, emphasizing its relevance in tumor immunity. Using these findings, we developed a deep learning model by the Multi-Layer Aggregation Graph Neural Network method. This model exhibited promise in predicting ICI treatment efficacy, suggesting its potential application in clinical practice.
first_indexed 2024-04-24T23:15:18Z
format Article
id doaj.art-b71bc1447dba4255ae3a8c24d822eb02
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-04-24T23:15:18Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-b71bc1447dba4255ae3a8c24d822eb022024-03-17T07:57:30ZengElsevierHeliyon2405-84402024-03-01105e27151Synergistic role of activated CD4+ memory T cells and CXCL13 in augmenting cancer immunotherapy efficacyWenhao Ouyang0Qing Peng1Zijia Lai2Hong Huang3Zhenjun Huang4Xinxin Xie5Ruichong Lin6Zehua Wang7Herui Yao8Yunfang Yu9Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medicine Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medicine Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaClinical Medicine College, Guangdong Medical University, Zhanjiang, ChinaClinical Medicine College, Guilin Medical University, Guilin, ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medicine Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medicine Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaFaculty of Medicine, Macau University of Science and Technology, Taipa, Macao, ChinaFaculty of Medicine, Macau University of Science and Technology, Taipa, Macao, ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medicine Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Corresponding author. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Phase I Clinical Trial Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, No. 107 Yanjiang West Road, Guangzhou 510120, China.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medicine Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Faculty of Medicine, Macau University of Science and Technology, Taipa, Macao, China; Corresponding author. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, No. 107 Yanjiang West Road, Guangzhou 510120, China.The development of immune checkpoint inhibitors (ICIs) has significantly advanced cancer treatment. However, their efficacy is not consistent across all patients, underscoring the need for personalized approaches. In this study, we examined the relationship between activated CD4+ memory T cell expression and ICI responsiveness. A notable correlation was observed between increased activated CD4+ memory T cell expression and better patient survival in various cohorts. Additionally, the chemokine CXCL13 was identified as a potential prognostic biomarker, with higher expression levels associated with improved outcomes. Further analysis highlighted CXCL13's role in influencing the Tumor Microenvironment, emphasizing its relevance in tumor immunity. Using these findings, we developed a deep learning model by the Multi-Layer Aggregation Graph Neural Network method. This model exhibited promise in predicting ICI treatment efficacy, suggesting its potential application in clinical practice.http://www.sciencedirect.com/science/article/pii/S2405844024031827Activated CD4+ memory T cellsImmunotherapyCXCL13Deep learning model
spellingShingle Wenhao Ouyang
Qing Peng
Zijia Lai
Hong Huang
Zhenjun Huang
Xinxin Xie
Ruichong Lin
Zehua Wang
Herui Yao
Yunfang Yu
Synergistic role of activated CD4+ memory T cells and CXCL13 in augmenting cancer immunotherapy efficacy
Heliyon
Activated CD4+ memory T cells
Immunotherapy
CXCL13
Deep learning model
title Synergistic role of activated CD4+ memory T cells and CXCL13 in augmenting cancer immunotherapy efficacy
title_full Synergistic role of activated CD4+ memory T cells and CXCL13 in augmenting cancer immunotherapy efficacy
title_fullStr Synergistic role of activated CD4+ memory T cells and CXCL13 in augmenting cancer immunotherapy efficacy
title_full_unstemmed Synergistic role of activated CD4+ memory T cells and CXCL13 in augmenting cancer immunotherapy efficacy
title_short Synergistic role of activated CD4+ memory T cells and CXCL13 in augmenting cancer immunotherapy efficacy
title_sort synergistic role of activated cd4 memory t cells and cxcl13 in augmenting cancer immunotherapy efficacy
topic Activated CD4+ memory T cells
Immunotherapy
CXCL13
Deep learning model
url http://www.sciencedirect.com/science/article/pii/S2405844024031827
work_keys_str_mv AT wenhaoouyang synergisticroleofactivatedcd4memorytcellsandcxcl13inaugmentingcancerimmunotherapyefficacy
AT qingpeng synergisticroleofactivatedcd4memorytcellsandcxcl13inaugmentingcancerimmunotherapyefficacy
AT zijialai synergisticroleofactivatedcd4memorytcellsandcxcl13inaugmentingcancerimmunotherapyefficacy
AT honghuang synergisticroleofactivatedcd4memorytcellsandcxcl13inaugmentingcancerimmunotherapyefficacy
AT zhenjunhuang synergisticroleofactivatedcd4memorytcellsandcxcl13inaugmentingcancerimmunotherapyefficacy
AT xinxinxie synergisticroleofactivatedcd4memorytcellsandcxcl13inaugmentingcancerimmunotherapyefficacy
AT ruichonglin synergisticroleofactivatedcd4memorytcellsandcxcl13inaugmentingcancerimmunotherapyefficacy
AT zehuawang synergisticroleofactivatedcd4memorytcellsandcxcl13inaugmentingcancerimmunotherapyefficacy
AT heruiyao synergisticroleofactivatedcd4memorytcellsandcxcl13inaugmentingcancerimmunotherapyefficacy
AT yunfangyu synergisticroleofactivatedcd4memorytcellsandcxcl13inaugmentingcancerimmunotherapyefficacy